Form D · Other Health Care
Upgrade Labs Inc.
Seattle, WA · CIK 0001741339
Offering snapshot reported Oct 23, 2018 · SEC filing
- Reported sold
- $6.45M Offering amount: $20M
- Investors reported
- 21 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Oct 11, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 23, 2018 | Initial | $6,450,871 | No comparison | 21 | SEC filing |
| Jun 12, 2018 | Initial | $100,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-324111
Source: Form D, filed Oct 23, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Asprey | Director |
| Dan Scholnick | Director |
| Martin Tobias | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
2212 Queen Anne Ave N Ste 827
Seattle, WA, 98109
Seattle, WA, 98109